SCHEMBL1768268

SCHEMBL1768268

CN(CC(=O)O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28825414 0.97 TDP1 (0.38)
Propene SCHEMBL11040490 0.89 MVD (0.33)
SCHEMBL5662442 0.82 MAOA (0.32)
Creatine SCHEMBL4007614 0.79 NOS3 (0.46)
SCHEMBL9214812 0.79 TDP1 (0.36)
Creatine SCHEMBL27979093 0.79 NOS3 (0.46)
Creatine SCHEMBL30063981 0.79
Creatine SCHEMBL21567 0.79
SCHEMBL13176709 0.79
SCHEMBL13862594 0.78

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320276-A1 NANOPARTICLE FORMULATIONS HTYR Acquistion LLC (US) 2025-10-16 US claimed
US-20250147048-A1 METHODS OF DIAGNOSTIC SCREENING AND EARLY DETECTION OF ADENOMYOSIS ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA 2025-05-08 US claimed
EP-4242298-A2 NANOPARTICLE FORMULATIONS Taiga Biotechnologies, Inc. (US) 2023-09-13 EP claimed
US-11116796-B2 Nanoparticle formulations TAIGA BIOTECHNOLOGIES, INC. (US) 2021-09-14 US claimed
CN-113307858-A Nanoparticle formulations 泰加生物工艺学公司 2021-08-27 CN claimed
US-20200222464-A1 NANOPARTICLE FORMULATIONS TAIGA BIOTECHNOLOGIES (ABC), LLC 2020-07-16 US claimed
EP-3548425-A1 NANOPARTICLE FORMULATIONS Taiga Biotechnologies, Inc. (US) 2019-10-09 EP claimed
WO-2018102678-A1 NANOPARTICLE FORMULATIONS TAIGA BIOTECHNOLOGIES, INC. (US) 2018-06-07 WO claimed
US-20180153939-A1 NANOPARTICLE FORMULATIONS HTYR ACQUISITION LLC 2018-06-07 US claimed
JP-4703186-B2 2011-06-15 JP claimed
EP-1527188-B1 PROCESS FOR THE PRODUCTION OF INCREASED AMOUNTS OF CORRECTLY FOLDED HETEROLOGOUS PROTEIN IN INCLUSION BODIES LEK PHARMACEUTICALS (SI) 2010-01-27 EP claimed
US-20050283000-A1 Process for the production of a heterologous protein LEK PHARMACEUTICALS D.D. (SI) 2005-12-22 US claimed
EP-1527188-A1 PROCESS FOR THE PRODUCTION OF INCREASED AMOUNTS OF CORRECTLY FOLDED HETEROLOGOUS PROTEIN IN INCLUSION BODIES LEK Pharmaceuticals D.D. (SI) 2005-05-04 EP claimed
WO-2004015124-A1 PROCESS FOR THE PRODUCTION OF A HETEROLOGOUS PROTEIN LEK PHARMACEUTICALS D.D. (SI) 2004-02-19 WO claimed
EP-0498260-B1 Procedure for stabilization of 1-methylhydantoinase, use of a stabilized 1-methylhydantoinase for the determination of an analyte, corresponding determination procedure, and useful means therefor BOEHRINGER MANNHEIM GMBH (DE) 1995-09-13 EP claimed
US-5374546-A Process for stabilizing 1-methylhydantoinase, use and method of it for determining an analyte and agents suitable for this BOEHRINGER MANNHEIM GMBH (DE) 1994-12-20 US claimed
EP-0498260-A1 Procedure for stabilization of 1-methylhydantoinase, use of a stabilized 1-methylhydantoinase for the determination of an analyte, corresponding determination procedure, and useful means therefor Roche Diagnostics GmbH (DE) 1992-08-12 EP claimed
EP-0112571-B1 METHOD AND REAGENT FOR THE DETERMINATION OF N-CARBAMOYLSARCOSINE, AND AN ENZYME THEREFOR Roche Diagnostics GmbH (DE) 1987-08-05 EP claimed
US-4645739-A USING A HYDROLASE TO OBTAIN SARCOSINE; KITS BOEHRINGER MANNHEIM GMBH (DE) 1987-02-24 US claimed
EP-0112571-A1 Method and reagent for the determination of N-carbamoylsarcosine, and an enzyme therefor Roche Diagnostics GmbH (DE) 1984-07-04 EP claimed